Georg-Speyer-Haus. Foto: Andreas Reeg, andreasreeg.com
Georg-Speyer-Haus. Foto: Andreas Reeg, andreasreeg.com
Research

“We are not masters, but students of nature.”

Paul Ehrlich

About us

Our institute was founded in 1904 as the private foundation Chemotherapeutic Research Institute Georg-Speyer-Haus to create a research site for Paul Ehrlich, the first director of Georg-Speyer-Haus. At today’s Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, oncological research is conducted. Our goal is to better understand the molecular and cellular basis of tumor development and to find new approaches for cancer therapy.

Funding

The Georg-Speyer-Haus is linked to the Goethe University Frankfurt am Main by a cooperation agreement and is funded by the Hessian Ministry of Science and Art and the Federal Ministry of Health. In addition, our scientists can draw third-party funding from public and private research funding organizations, from cooperation agreements with companies, from income from the foundation’s capital, and from donations. Since 2013, Prof. Florian Greten, MD, has headed the institute as director. Prof. Greten is also an executive member of the Foundation’s Board of Directors, which includes Deputy Director Prof. Dr. Winfried Wels and Commercial Director Franziska Hasslinger-Pajtler as additional members. The Board of Directors manages the day-to-day business of the Foundation and is responsible to the Board of Trustees in this capacity.